Shanghai Pharmaceuticals Holding Co., Ltd (601607.SS) Stock
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally.
Valuation
Financials & Margins
About Shanghai Pharmaceuticals Holding Co., Ltd
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as invests in equity. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.
Shanghai Pharmaceuticals Holding Co., Ltd is led by CEO Qiuhua Yang, employs 48,640 people, headquartered in Shanghai, CN, publicly traded since 1994.
Shanghai Pharmaceuticals Holding Co., Ltd (601607.SS) stock trades at $16.50 with a market capitalization of $61.19B. The stock is valued at a price-to-earnings (P/E) ratio of 12.79, price-to-book of 0.78, price-to-sales of 0.21. Over the past 52 weeks the stock has ranged between $15.01 and $18.56, and currently trades 11.1% below its 52-week high. It pays a dividend yielding 2.69%.
On profitability, Shanghai Pharmaceuticals Holding Co., Ltd generates a return on equity (ROE) of 6.96%, an operating margin of 3.56%, a net profit margin of 1.65%.
The balance sheet shows a debt-to-equity ratio of 0.63, a current ratio of 1.34.
601607.SS has an average daily trading volume of 11,440,493 shares, a beta of 0.22 (historically less volatile than the overall market), 2.79B shares outstanding.
Official website: www.sphchina.com
Shanghai Pharmaceuticals Holding Co., Ltd (601607.SS) — frequently asked questions
What is Shanghai Pharmaceuticals Holding Co., Ltd (601607.SS) stock price today?
Shanghai Pharmaceuticals Holding Co., Ltd (601607.SS) is currently trading at $16.50, up 0.3% today.
What is 601607.SS P/E ratio?
Shanghai Pharmaceuticals Holding Co., Ltd's P/E ratio is 12.79. This is below the typical market average of roughly 18-22x. A low P/E can reflect a lower valuation, slower expected growth, or both.
What is 601607.SS return on equity (ROE)?
Shanghai Pharmaceuticals Holding Co., Ltd's return on equity (ROE) is 6.96%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is Shanghai Pharmaceuticals Holding Co., Ltd's market cap?
Shanghai Pharmaceuticals Holding Co., Ltd has a market capitalization of $61.19B.
Does 601607.SS pay a dividend?
Yes. Shanghai Pharmaceuticals Holding Co., Ltd currently yields 2.69%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 601607.SS carry?
Shanghai Pharmaceuticals Holding Co., Ltd has a debt-to-equity ratio of 0.63. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 601607.SS's profit margin?
Shanghai Pharmaceuticals Holding Co., Ltd reports a net profit margin of 1.65% — the share of revenue left after every cost, including tax and interest.
What sector is 601607.SS in?
Shanghai Pharmaceuticals Holding Co., Ltd is classified under Healthcare, in the Medical Distribution industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 601607.SS listed on?
Shanghai Pharmaceuticals Holding Co., Ltd trades on SHH under the ticker 601607.SS.
What is 601607.SS's 52-week range?
Over the last year Shanghai Pharmaceuticals Holding Co., Ltd has traded between $15.01 and $18.56.
Related Healthcare Stocks
Popular Stocks
Screens 601607.SS currently matches
On the figures above, Shanghai Pharmaceuticals Holding Co., Ltd passes the filters for 13 of our ready-made screens, among them Low PB Stocks, Dividend Stocks, Blue Chip Dividend Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.